pharmacology Flashcards
Routes of administration
Parenteral – injection such as subcutaneous, intramuscular, intravenous or epidural
Enteral – oral, nasogastric or rectal
Topical - rectal, inhalation, vaginal, sublingual or dermal
Forms of drugs
solid form - capsules, tablets and trochees
liquid forms - syrups, solutions, aqueous suspensions, elixirs, tinctures and gases
ointments, pastes, lotions, suppositories
Absorption
Absorption refers to the process of how the drug enters the systemic circulation from the point of administration.
It describes how the drug is released from the formulation and how it enters into the circulation. With other words from application to distribution
Factors affecting absorption
-Lipid water solubility
Lipid water solubility coefficient is the ratio of dissolution of drug in lipid as compared to water. Greater the lipid water solubility coefficient, more is the lipid solubility of the drug and greater is the absorption. Less the coefficient, less is the lipid solubility and less is the absorption.
- Molecular size
Smaller the molecular size of the drug, rapid is the absorption. - Particle size
Larger is the particle size, slower will be the diffusion and absorption and vice versa. - Degree of Ionization
Different drugs are either acidic or basic and are present in ionized or unionized form. - Physical Forms
Drugs may exist as solids, liquids or gases - Chemical Nature
Chemical nature is responsible for the selection of the route of administration of drug. - Dosage Forms
Dosage forms affect the rate and extent of absorption. A drug can be given in the form of tablets, capsules or transdermal packets. Injections may be aqueous or oily. This changes the rate of absorption. - Formulation
When the drugs are formed, apart from the active form some inert substances are included. - Concentration
higher the concentration more flux occurs across the membrane. The rate is less affected than the extent of absorption.
Factors Related to Body
1. Area of Absorptive Surface
- Vascularity
- pH
- Presence of other Substances
- GI Mobility
- Functional Integrity of Absorptive Surface
- Diseases
Distribution
Distribution is the process whereby the drugs are moved around the body from site of absorption to site of action and finally to the site of excretion.
The factors that affect distribution include
amount of drugs available
blood flow, vascularisation
amount of plasma proteins
water in fluid compartments
Drugs are carried in the blood in 2 forms
attached to proteins (protein-bound) or in the free form (unbound).
free drug
The free (non-protein-bound) drug is dissolved in solution and can enter cells directly.
protein bound
The protein-bound is attached to protein. This binding is reversible because the drug needs to be released from the protein before entering cells. This form of drug transport acts like a reservoir
Metabolism
Metabolism or biotransformation is the process of how the body breaks down the drugs.
where does most metabolism take place
liver
metabolism is necessary to
activate pro-drugs inactivate drugs (normal process) change drugs to water-soluble forms for excretion
Factors affecting metabolism include
hepatic function and the hepatic first-pass effect genetic differences (enzymes) eg PKU, porphyria interference of other drugs (interaction) concomitant diseases (renal, liver disease) metabolic status (age, weight) drug storage (fat)
The hepatic first-pass effect refers to
The hepatic first-pass effect refers to enteral drugs which once they are absorbed, have to go to the liver first before reaching the target organ. This means that some of the drugs will already be metabolized before reaching the systemic circulation.
Bio availability
Bioavailability is the fraction (proportion) of the active drug which reaches the target organ and which can thus produces a biological effect.
The bioavailability is affected by amount of drug absorbed and the metabolism in the first-pass phenomenon through the liver.
A low bioavailability means that most of the drug is lost or destroyed before actually reaching the target cells.
Excretion or elimination is
the removal of any part of the drug which is no longer used by the body.
The body can eliminate chemicals by various means. These include bile and faeces, urine, exhalation of air, sweat or saliva, breast milk and vomiting.
Pharmacodynamics is
Pharmacodynamics is the pharmacological mode of action or effect of the drug. It is the action of drugs on living tissue.
It can also be defined as the biological effects produced by the interaction of a drug and the target site (cells, fluids, receptors).
therapeutic effect
minimum effective concentration
the pharmacological action of drugs can be put into 2 categories
- non-receptor mediated and receptor mediated.
The receptor mediated actions are more specific and can be on
- receptors on the cell membrane or receptors inside the cell
- enzymes
The non-receptor mediated actions include
- physical
- chemical
- antibody
- placebo
second messenger concept
Receptors on the cell membrane (outside) can be activated by a drug which binds to the receptor.
The drug is the 1st messenger and is lipophobic (water-soluble) and cannot diffuse across the cell membrane.
The drug-receptor binding activates the 2nd messenger inside the cell and this alters cell activity.
Steroid hormones or lipid-soluble drugs
can directly enter the cells
protein hormones or lipid-insoluble drugs
work by second messenger
1st messenger concept
Receptor inside the cell will be activated by drugs that are lipophilic (water-insoluble), which have diffused across the cell membrane.
The 1st messenger (drug) enters the cells and directly alters cell activity.
Enzyme action
Enzymes also have receptors and drugs binding to these receptors can activate or inhibit the enzyme action.
The following are examples of drugs which inhibit enzymes. Angiotensin-converting enzymes (ACE) play a role in blood pressure control. ACE inhibitors are used to lowers blood pressure.
Specificity is the
ability of the drug to bind to a receptor. It depends on the chemical structure of the drug and the specific fit with a receptor (lock and key).
The affinity is the
strength of binding of drug and receptor.
Efficacy is the
magnitude of effect (maximum effect) the drug can have.
The potency of a drug is the
strength of the drug (amount of drug needed to get the effect).
A drug that is an agonist
mimics natural neurotransmitters, hormones or chemical by stimulating receptors eg adrenaline and nor-adrenaline. These drugs have affinity and efficacy and specificity.
An antagonist is
when a drug combines with a receptor but does not produce a biological response, or prevents other molecules from binding to the receptor, thus not producing a response.
Minimum effective concentration (MEC) or therapeutic level is
the lowest drug plasma level at which the drug produces the desired drug effect (therapeutic effect).
The toxic level is
when the drug plasma level at which the drug produces serious adverse effects.
The loading dose is
an initial larger dose given to reach a steady state quicker.
The maintenance dose
is the dose needed to keep the plasma levels in the therapeutic range/steady state.
The duration of action
covers the time when there is enough drug to cause a response.
Dose interval is
the time between doses of a drug.
The onset of action
is the time from administration of the drug to the first clinical response.
Side Effect or type A reaction
These are known, undesirable response to a drug at normal drug dosage. They are usually predictable, a secondary effect and unavoidable.
Side effects are related to the mechanism of drug action, the characteristic of the drug.
Adverse reaction or type B reaction
These are any unintended, undesirable effect due to drug administration at normal dosages.
The effects are unexpected and unpredictable. They can be dangerous, bizarre, or idiosyncratic and are due to patient characteristics, not related to the mechanism of drug action.
Drug interactions
Drugs can interact with each other in their passage through the body (pharmacokinetics) or at the site of action (pharmacodynamics).
A pharmacokinetic interaction is
where one drug interferes with the absorption or metabolism of another drug
Pharmacodynamic interactions are
where one drug interferes with the effects of another at the cellular level (agonist, antagonist, desirable, undesirable).
Monitoring the patient and the effects
Baseline vital signs Compliance Therapeutic (clinical) effect Plasma concentrations Side effects and adverse reactions Toxicity
Clinical response to adverse drug reaction should include
Discontinue administration or modifying the dose
Prevent further absorption – gastric lavage, haemodialysis
Hospitalise client – monitor signs and symptoms, blood levels
Provide supportive measures
Antidote – atropine or naloxone
Increase elimination - diuretics
Record event
Contraindications refer to
situations when a drug is not recommended eg age, pregnancy, allergies
Adrenergic medications work on the
sympathetic nervous system, affecting the central nervous system and the peripheral alpha- and beta-receptors.
Beta-blockers are used to
reduce the myocardial workload (reduce the force of contraction and reduce the rate of contraction).
Alpha-blockers have a
vasodilatory effect on the blood vessels, thus lowering the blood pressure.
The therapeutic effect of beta-blockers is to
The therapeutic effect of beta-blockers is to reduce the force of contraction of the myocardium (negative inotropic effect) and to reduce the heart rate (negative chronotropic effect). This reduces the myocardial oxygen demand and prevents or reduces myocardial ischaemia.
The pharmacological effect of alpha-blockers is
smooth muscle relaxation in the arteries thus reducing the afterload and decreasing blood pressure.
Labetalol is indicated
in pregnancy and mainly has an alpha-blocking effect and is a lesser beta-blocker.
Methydopa is a
centrally acting sympatholytic used in hypertensive crises. Methyldopa does not reduce renal or cardiac function like some of the other adrenergic blockers. Because of the effect on the brainstem, the client may experience drowsyness.
Calcium channel blockers are used in
the treatment of arhythmias, angina and hypertension.
The pharmacological action of these drugs
embedded in the name - these drugs stop calcium entering the cells by blocking the calcium channels (pores). The result is smooth muscle relaxation. Not all calcium channel blockers have the same therapeutic effect.
When the coronary arteries dilate
more oxygenated blood can flow to the myocardium and angina is relieved.